News - Grunenthal

Filter

Current filters:

Grunenthal

Popular Filters

Grunenthal aims to strengthen Latin America business, appointing exec VP for the region; Novartis cancels Vasella deal

19-02-2013

German family-owned drugmaker Grunenthal Group announced the appointment of Oscar Ferenczi, former region…

GrunenthalManagementNovartisPharmaceutical

Grunenthal sees core business sales grow 9% as EBITA leaps 147%

13-09-2012

German family-owned drugmaker Grunenthal reported first-half 2012 revenues of 473 million euros ($597.6…

FinancialGrunenthalPharmaceutical

Grunenthal to present strong R&D pipeline at BIO 2012

17-06-2012

German family-owned research-based drugmaker Grunenthal last week outlined its strong R&D pipeline of…

GrunenthalNeurologicalPharmaceuticalResearch

STADA and Grunenthal agree lower price for certain branded products

30-01-2012

German drugmakers STADA Arzneimittel (SAZ: GR) and family-owned Grunenthal have agreed on the purchase…

EuropeGenericsGrunenthalMergers & AcquisitionsSTADA Arzneimittel

STADA pulls out of part of Grunenthal deal

04-01-2012

German drugmaker STADA Arzneimittel AG (SAZ: GR) says it has exercised its contractual right to withdraw…

EuropeGrunenthalMergers & AcquisitionsPharmaceuticalRest of the WorldSTADA Arzneimittel

Endo Pharma pulls out of axomadol deal with Grunenthal

19-08-2011

USA-based Endo Pharmaceuticals (Nasdaq: ENDP) says that it is terminating its research program and collaboration…

axomadolEndo PharmaceuticalsGrunenthalLicensingNeurologicalPharmaceuticalResearch

Stada confirms 360 million-euro buy of Grunenthal branded product portfolio

26-07-2011

German drugmaker Stada Arzneimittel (SAZ: GR) and have confirmed the previously-flagged signing of a…

GrunenthalMergers & AcquisitionsPharmaceuticalSTADA Arzneimittel

Grunenthal debuts novel severe pain drug Palexia SR in UK

16-05-2011

Family-owned German drugmaker Grunenthal has today launched Palexia SR (tapentadol prolonged release)…

EuropeGrunenthalMarkets & MarketingNeurologicalPalexiaPharmaceuticaltapentadol

Back to top